Cancer Treatments - Alternative and Complementary
Commentary by Thomas Sullivan
|
|
What is the difference between alternative and complementary treatments? We define alternative cancer treatments as those modalities that are outside the current mainstream of known and established cancer treatments which may replace a current treatment. Complementary treatments on the other hand are designed to be used as an adjunct to a traditional cancer treatment. Although the news presented here may be both positive and negative, for sure, you will be informed.
Our mission here is to provide the most current information on alternative and complementary cancer treatments. We will leave it up to the doctor and patient to concomitantly decide if the treatment is appropriate. It is up to the patient and physician to know what cutting edge treatments are available. This news journal provides a means by which to increase the treatment knowledge base. This news journal will be updated at least once per day.
For the cancer patient, information can increase his or her chance of survival. If you find a news post which stimulates your interest, you should consult with your oncologist about possibly pursuing that particular treatment. This news journal provides information on alternative and complementary cancer treatments only, and we do not endorse any of the treatments presented. We simply want to let you know that there are alternative and complementary treatments available. Our goal here is to simply provide the most current news in terms of alternative and complementary cancer treatments.
Because the oncologist must deal with many types of cancer, keeping up on the absolutely latest treatments and non-mainstream medical modalities, can be difficult. There are over 200 different types of cancer. You can develop cancer in any body organ. There are over 60 different organs in the body where you can get a cancer.
The prudent patient should concentrate on his or her particular cancer. You may find some information that your oncologist may not be aware of. The prudent patient should thoroughly research the available treatments, both mainstream and non-mainstream that may exist.
One thing is clear…the most promising treatment programs are integrating traditional and non-traditional approaches. It is our hope that this frequently updated news journal becomes a viable sources of information for both patient and oncologist. We encourage you to bookmark this journal and view it daily to keep up on what is happening in terms of new cancer treatments.
The following are informative videos, related articles, current news about alternative and complementary cancer treatments, and general cancer treatment news. While the diagnosis of malignant cancer is something most of us can do without, medical research has brought to the table an assortment of treatment alternatives that did not exist even 10 or 15 years ago. Review the following news frequently, and if you find something that sparks your interest and is relevant to your situation, discuss the information with your oncologist. Simply put, being informed increases the chances of survival.
HolisticCancerSolutions.com is the website of Eclectic Medicine International (E.M.I.), a 15-year old medical data research and information service firm, focusing on non-toxic medications and therapies. They provide some very interesting reports. To learn more about what they have to offer to the cancer patient, click the following link:(Make sure you click their “About Us” link to learn more about their reports and for ordering)
|
|
Cancer Treatments - Alternative and Complementary - Videos
|
|
|
|
STOP! You must read this information before you decide about your cancer treatment. Over 350 non-toxic natural and alternative treatments that have helped thousands of people beat their cancer. Over 2,000 testimonials! Success rates for surgery, chemo and radiation revealed! Free information on financial and other help available. Download this set of 4 e-Books and Reports NOW. It could save your life.
The set of e-books and reports at www.naturalcancertreatments.com gives you EVERYTHING you need to know about natural and alternative treatments for cancer.
The Following is News About Alternate Cancer Treatments, Clinical Trials, Modalities Outside Mainstream Medicine, and General Cancer Treatment News:
Cancer Treatments - Alternative and Complementary - Treatment News
|
Cancer Is Easy To Overcome – I’ll Show You How |
|
Cancercompass News: top stories
@copy; Copyright 2009, International Capital & Management Company, LLLP. All Rights Reserved.
CancerCompass is an online community committed to offering people living with cancer a place to receive cancer information and news, share knowledge, and share cancer treatment experiences. To learn more, visit our site today.
Access Pharmaceuticals Provides Update On Prolindac Phase 2 Ovarian Cancer Trial And Clinical Development Plan
Access Pharmaceuticals, Inc., provided an update today on the progress in the Company's clinical development plan for ProLindac, a novel DACH platinum drug that has shown to be active in many solid tumor types in human clinical studies. Access recently announced positive safety and efficacy results from its Phase 2 monotherapy clinical study of ProLindac(TM) in late-stage, heavily pretreated ovarian cancer patients. In this study, 66% of patients who received the highest dose achieved clinically meaningful disease stabilization according to RECIST criteria. No patient in any dose group exhibited any signs of acute neurotoxicity, which is a major adverse side-effect of the approved DACH platinum, Eloxatin, and ProLindac was well tolerated ov...
New Data Support Use Of Simple Test To Predict Endometrial Cancer Response To Chemotherapy
New data presented today at the 2009 American Society of Clinical Oncologist (ASCO) Annual Meeting support the use of a laboratory test, ChemoFX(R), to help physicians predetermine the effectiveness of chemotherapy in treating a woman's endometrial cancer. Investigators found a significant correlation between the test results from 405 patient specimens analyzed using ChemoFx and published patient response rates for each chemotherapeutic regimen, suggesting less effective therapies could be eliminated prior to patient administration. Endometrial cancer is the most common gynecologic cancer among women in the United States. "Limiting a patient's exposure to chemotherapy is important, however determining the appropriate treatment the first...
New Colon Cancer Study Findings Have Been Published By Scientists At Arizona State University
According to a study from the United States, "African Americans are more likely than any other racial or ethnic group to develop colorectal cancer (CRC) and to die as a result. Factors such as age, family history, income, knowledge, attitudes and beliefs regarding screening are important predictors of risk, and multiple factors may contribute to poor CRC outcomes for African Americans." "Although screening is not the only factor associated with CRC outcomes, it may be one of the more important and modifiable risk factors for African Americans. Few programs have utilized narrative approaches to promote cancer screening among African Americans. None have focused on CRC screening," wrote A.G. Robillard and colleagues, Arizona State Universi...
Genetic Testing For Breast Or Ovarian Cancer Risk May Be Greatly Underutilized
Although a test for gene mutations known to significantly increase the risk of hereditary breast or ovarian cancer has been available for more than a decade, a new study finds that few women with family histories of these cancers are even discussing genetic testing with their physicians or other health care providers. In a report in the Journal of General Internal Medicine, which has been released online, investigators from the Massachusetts General Hospital (MGH) Institute of Health Policy and Dana-Farber Cancer Institute note that their findings illustrate the challenges of bringing genetic information into real-world clinical practice. "Testing for BRCA1 and 2 mutations has been around a long time and should be a good indicator of whe...
Individuals Who Apply Pesticides Are Found To Have Double The Risk Of Blood Disorder
WASHINGTON -- A study involving 678 individuals who apply pesticides, culled from a U.S. Agricultural Health Study of over 50,000 farmers, recently found that exposure to certain pesticides doubles one's risk of developing an abnormal blood condition called MGUS (monoclonal gammopathy of undetermined significance) compared with individuals in the general population. The disorder, characterized by an abnormal level of a plasma protein, requires lifelong monitoring as it is a pre-cancerous condition that can lead to multiple myeloma, a painful cancer of the plasma cells in the bone marrow. The study will appear in the June 18 issue of Blood, the official journal of the American Society of Hematology. "Previously, inconclu...
LSU Health Sciences Center Research Finds Single Gene Controls Growth Of Some Cancers
NEW ORLEANS -- Research led by Ashok Aiyar, PhD, Associate Professor of Microbiology at LSU Health Sciences Center New Orleans, showing that a single gene can control growth in cancers related to the Epstein-Barr virus and that existing therapeutics can inactivate it, will be published in the June 12, 2009 online issue of PLoS Pathogens. The Epstein-Barr virus (EBV) is closely associated with many human cancers such as Burkitt's lymphoma, Hodgkin's lymphoma, AIDS-related lymphomas, post-transplant lymphoproliferative disease, cancers of the nose and throat, and stomach cancer. In many of these malignancies, proteins made by EBV are necessary for tumor cells to grow indiscriminately. This is especially true of AIDS-relat...
Research Data From Institute Of Cancer Research Update Understanding Of Breast Cancer Prevention
Fresh data on breast cancer are presented in the report 'Pregnancy in the mature adult mouse does not alter the proportion of mammary epithelial stem/progenitor cells.' According to a study from London, the United Kingdom, "In humans, an early full-term pregnancy reduces lifetime breast cancer risk by up to 50% whereas a later pregnancy (>35 years old) can increase lifetime risk. Several mechanisms have been suggested, including changes in levels of circulating hormones, changes in the way the breast responds to these hormones, changes in gene expression programmes which may alter susceptibility to transformation and changes to mammary stem cell numbers or behaviour." "Previous studies have shown that the mammary tissue isolated from bot...
Telik Presents Results At ASCO From Assist-5 Trial Of Telcyta In Platinum Refractory And Resistant Ovarian Cancer
Telik, Inc. announced presentation at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Orlando, Florida, of results from the ASSIST-5 Phase 3 randomized, multinational study of TELCYTA(R) (canfosfamide HCl) in combination with pegylated liposomal doxorubicin (PLD) vs. PLD alone in second-line therapy in platinum refractory or resistant ovarian cancer. Study Design: Patients with platinum refractory or resistant ovarian cancer (platinum refractory, primary platinum resistant, secondary platinum resistant) by standard GOG criteria, with measurable disease were eligible for enrollment in the trial. A total of 125 patients at sites in the USA (44), Brazil (15), Belgium (8) and UK (6) were randomized with a 1:1 a...
Metastatic Colon Cancer Survival Rises
HOUSTON -- Novel chemotherapy and biological agents for metastatic colorectal cancer has resulted in increased patient survival, U.S. researchers say. Researchers at the University of Texas M.D. Anderson Cancer Center in Houston said researchers have made great strides in identifying active agents for the disease, resulting in U.S. Food and Drug Administration approval of numerous chemotherapeutic agents. The study, published in the Journal of Clinical Oncology, found that the median overall survival is now more than 30 months, compared with eight months for patients diagnosed before 1990. Five-year survival of patients diagnosed with the disease after 2004 is more than 30 percent. "In this study, we wanted to deter...
New Data Support Use Of Simple Test To Predict Endometrial Cancer Response To Chemotherapy
ORLANDO, Fla. -- New data presented today at the 2009 American Society of Clinical Oncologist (ASCO) Annual Meeting support the use of a laboratory test, ChemoFX(R), to help physicians predetermine the effectiveness of chemotherapy in treating a woman's endometrial cancer. Investigators found a significant correlation between the test results from 405 patient specimens analyzed using ChemoFx and published patient response rates for each chemotherapeutic regimen, suggesting less effective therapies could be eliminated prior to patient administration. Endometrial cancer is the most common gynecologic cancer among women in the United States. "Limiting a patient's exposure to chemotherapy is important, however determining t...
Staying Positive Key In Fight Against Cancer
Eleven years ago, Harris was diagnosed with breast cancer after she discovered her own lump through a self-examination. After having a mammogram and sonogram, she decided to have surgery as soon as possible. "After she [my doctor] told me I had cancer, I said, 'Well, am I going to die?' and she said 'No,'" Harris said. "So I think it's a mind over matter thing and 99.9 percent is your attitude." The support of family and friends also helped Harris while she received chemotherapy and radiation treatments, who noted staying occupied helps to reduce the amount of negative thinking. "It works on you," Harris said. "I came back to work after a certain length of time and I think that also helped. If you don't have family...
HRT-Breast Cancer Risk Stays Same, Regardless Of Family History
The risk of developing breast cancer due to taking hormone replacement therapy appears to be the same for women with a family history of the disease and without a family history, a University of Rochester Medical Center study concluded. The study, published online this week in the journal Epidemiology, adds to the evolving picture of what factors, either alone or in combination, boost breast cancer risk among postmenopausal women. It also refutes the notion, held by many in the medical community, that a familial predisposition to breast cancer enhances the carcinogenic effects of estrogen. "Although we know that family history is a risk factor, we don't know yet what it is about family history that conveys the risk," said Robert E. Gr...
New Therapies To Treat Breast, Lymph Cancer: Studies
New therapies developed following groundbreaking clinical trials appear to effectively target breast cancer and non-Hodgkin's lymphoma, according to research unveiled Sunday at a major cancer conference. The first therapy targeting the capacity of cancer cells to repair themselves shows promise in treating breast cancer, according to results of two small clinical trials. The new agent, especially adept at targeting cancers that are most difficult to cure, neutralizes an enzyme called PARP (poly-ADP-ribose-polymerase) and prevents it from playing its usual role in repairing the DNA of damaged cells. Like healthy cells, cancerous cells employ PARP to regenerate themselves after they have been damaged by chemo-therapy treatments. T...
Study Suggests Drug Combos May Raise Breast Cancer Risk
Breast cancer survivors risk having their disease come back if they use certain antidepressants while also taking the cancer prevention drug tamoxifen, worrisome new research shows. About 500,000 women in the United States take tamoxifen, which cuts in half the chances of a breast cancer recurrence. Many of them also take antidepressants for hot flashes, because hormone pills aren't considered safe after breast cancer. Doctors have long known that some antidepressants and other medicines can lower the amount of tamoxifen's active form in the bloodstream. But whether this affects cancer risk is unknown. The new study, reported Saturday at a cancer conference in Florida, is the largest to look at the issue. It found that using these...
Gene Signature Helps Predict Breast Cancer Prognosis
Vanderbilt-Ingram Cancer Center researchers have uncovered a gene signature that may help predict clinical outcomes in certain types of breast cancer. In the Journal of Clinical Investigation, Harold (Hal) Moses, M.D., and colleagues report that this gene signature which is associated with the transforming growth factor-beta (TGF- & #946;) signaling pathway correlates with reduced relapse-free survival in patients with breast cancer, especially in those with estrogen receptor (ER) positive tumors. The results suggest that assessing TGF- & #946; signaling may be a useful aid in determining breast cancer prognosis and in guiding treatment. The work also sheds light on how TGF- & #946; affects tumor growth and progression. TGF- & #9...
cancer treatment - Google News
©2009 Google
Google News
Lack of Evidence Hinders Cancer Treatment in Elderly - Wall Street Journal
Lack of Evidence Hinders Cancer Treatment in Elderly Wall Street Journal And Ted wanted an aggressive treatment that would give him the best chance of sending his cancer into remission. But Ted's history of heart trouble meant he ... The Need for New Research to Include Old Patients |
Biomarker That Safely Monitors Tumor Response To New Brain Cancer ... - Science Daily (press release)
Biomarker That Safely Monitors Tumor Response To New Brain Cancer ... Science Daily (press release) ... gauge the response to a novel gene therapy treatment for glioblastoma mulitforme. The finding, reported in the July 1 issue of Clinical Cancer Research, ... |
Cancer Treatment Centers of America (CTCA) hiring at corporate ... - Examiner.com
Cancer Treatment Centers of America (CTCA) hiring at corporate ... Examiner.com Do you have a deep concern and interest in curing Cancer? Are you aspiring to put your experience and skills to work for a good cause? The Cancer Treatment ... Cancer Treatment Centers of America Selects MedAssets' Spend ... |
Rally for the Cure golf tournaments raise money for breast cancer ... - Grand Junction Sentinel
Rally for the Cure golf tournaments raise money for breast cancer ... Grand Junction Sentinel “I know somebody who's going through (breast cancer) treatment right now,” she said. She has high praise for the efforts the Susan G. Komen Foundation has ... |
BYU's Rose to return after cancer treatment - Rivals.com (subscription)
BYU's Rose to return after cancer treatment Rivals.com (subscription) After undergoing emergency surgery for pancreatic cancer earlier this month, Rose announced last week that his tumor had been removed and that his cancer ... |
New Cancer Treatment Shows Promise in Testing - New York Times
 China Daily | New Cancer Treatment Shows Promise in Testing New York Times The method is intended to sidestep two major drawbacks of standard chemotherapy: the treatment's lack of specificity and the fact that cancer cells often ... New Trojan Horse Treatment Sneaks Into, Sabotages Cancer Cells Scientists kill cancer cells with "trojan horse" “Trojan Horse” Used to Terminate Cancer Cells |
Poniard Pharmaceuticals (PARD) Rallies on Cancer Treatment - TransWorldNews (press release)
Poniard Pharmaceuticals (PARD) Rallies on Cancer Treatment TransWorldNews (press release) ... hit new 52-week highs today, largely propelled by recent news regarding its Phase III trial of Picoplatin for the treatment of small cell lung cancer. ... |
Specter plans hearing on VA prostate cancer treatment - Philadelphia Inquirer
 Dog Flu Diet and Diseases | Specter plans hearing on VA prostate cancer treatment Philadelphia Inquirer Ricardo Flippin opted for a radiation therapy that would precisely target his prostate cancer and leave nearby organs unharmed. Instead, his prostate cancer ... Report: VA Hospital Botched Cancer Treatments VA cancer treatment causes more injury Newspapers: VA in Penn. botched cancer treatments |
US medical professionals question costly cancer treatment - AFP
 MSN Philippines News | US medical professionals question costly cancer treatment AFP WASHINGTON (AFP) — Two National Institutes of Health (NIH) practitioners have questioned the wisdom and utility of treating terminally ill cancer patients ... Cost of Cancer Drugs to Force Hard Decisions Are cancer meds worth the cost? Cost-Effectiveness of Cancer Drugs Is Questioned |
Result of prostate cancer treatment debate could have big impact ... - Florida Times-Union
Result of prostate cancer treatment debate could have big impact ... Florida Times-Union Localized prostate cancer treatment, which can range from "active surveillance" to zapping the cancerous cells with proton radiation, ... |
Complementary Cancer Treatments - Google News
©2009 Google
Google News
Skin Deep Seeking Natural Remedies for Hot Flashes - New York Times
 New York Times | Skin Deep Seeking Natural Remedies for Hot Flashes New York Times The study was paid for by the National Center for Complementary and Alternative Medicine and the Office of Dietary Supplements. Results are due in the fall, ... |
Breast surgeon: A little knowledge can be dangerous - Times Herald-Record
Breast surgeon: A little knowledge can be dangerous Times Herald-Record "Your doctor should be willing to research alternative or complementary treatments you might be curious about," she says. "There's no reason not to listen ... Mastectomy patients need time to recover |
Cancer patients especially vulnerable - Times Herald-Record
Cancer patients especially vulnerable Times Herald-Record They call this complementary or integrative medicine because it is in addition to — not in place of — conventional treatments. ... |
New biomarker method may help detection of cancer in early stage - pharmabiz.com
New biomarker method may help detection of cancer in early stage pharmabiz.com This is a critical roadblock because biomarkers have the potential to allow doctors to detect cancer in the earliest stages, when treatment provides the ... |
Promise of holistic healing draws cancer patients to Mexico clinics - CNN
Promise of holistic healing draws cancer patients to Mexico clinics CNN The concept of complementary and alternative cancer treatment has slowly been gaining acceptance for more than a decade in the United States, ... |
Just For The Health Of It- Our cells respond to human touch - Billerica Minuteman
Just For The Health Of It- Our cells respond to human touch Billerica Minuteman There was a fascinating case report published in 2008 in the Journal of Alternative and Complementary Medicine. The findings suggest that external ... |
Thunder Partners with Cancer Treatment Centers of America - OurSports Central (press release)
Thunder Partners with Cancer Treatment Centers of America OurSports Central (press release) Theresa found herself at Cancer Treatment Centers of America because of its whole-body approach. She liked that the doctors and nurses made her feel like a ... |
Holistic care therapist: Take control of your health - Times Herald-Record
Holistic care therapist: Take control of your health Times Herald-Record "There's a visible underground movement (regarding cancer treatment)," she says. "Consider the number of people with cancer who have died. ... |
Breast Cancer Treatment Options - Why Having Choices is So Important - EmpowHer
Breast Cancer Treatment Options - Why Having Choices is So Important EmpowHer ... I came across several medical facilities that offer breast cancer treatment options that include both traditional and complementary medicine. ... |
After Farrah, Her Doctor's Next Fight: 'She's a Role Model for All ... - Newsweek
After Farrah, Her Doctor's Next Fight: 'She's a Role Model for All ... Newsweek The studies say that RIT has the best results, in terms of duration of remissions, among all lymphoma cancer treatments. So why do so few patients take ... |
Cancer blog from medicineworld.org
Cancer blog from medicineworld.org adds a personal touch to the stories related to cancer. This cancer blog brings you stories of hope, stories of survivors and latest news and research related to cancer.
New Clues To Understanding Cancer
In the 13th January print edition of the journal Current Biology, Instituto Gubenkian de Ciencia scientists provide insight into an old mystery in cell biology, and offer up new clues to understanding cancer. Ins Cunha Ferreira and Mnica Bettencourt Dias, working with scientists at the universities of Cambridge, UK, and Siena, Italy, unravelled the mystery of how cells count the number of centrosomes, the structure that regulates the cell's skeleton, controls the multiplication of cells, and is often transformed in cancer........
Insulin levels may have a say in breast cancer risk
Higher-than-normal levels of insulin place postmenopausal women at increased risk of breast cancer, scientists at Albert Einstein College of Medicine of Yeshiva University report. Their findings, reported in the January 7 issue of the Journal of the National Cancer Institute, suggest that interventions that target insulin and its signaling pathways may decrease breast cancer risk in these women........
New genes that fuse in cancer
Using new technologies that make it easier to sequence the human genome, scientists at the University of Michigan Comprehensive Cancer Center have identified a series of genes that become fused when their chromosomes trade places with each other. These recurrent gene fusions are believed to be the driving mechanism that causes certain cancers to develop........
New evidence for warburg theory of cancer
German scientist Otto H. Warburg's theory on the origin of cancer earned him the Nobel Prize in 1931, but the biochemical basis for his theory remained elusive. His theory that cancer starts from irreversible injury to cellular respiration eventually fell out of favor amid research pointing to genomic mutations as the cause of uncontrolled cell growth........
Hormone therapy and colorectal cancer
The combination of estrogen plus progestin, which women stopped taking in droves following the news that it may increase their risk of breast cancer, may decrease their risk of colorectal cancer, as per a report reported in the recent issue of Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research........
Cancer prevention properties of black raspberries
A study published in Cancer Prevention Research, a journal of the American Association for Cancer Research, identifies components of black raspberries with chemopreventive potential. Scientists at the Ohio State Comprehensive Cancer Center observed that anthocyanins, a class of flavonoids in black raspberries, inhibited growth and stimulated apoptosis in the esophagus of rats treated with an esophageal carcinogen........
Healthy cells Vs cancer cells
One of the current handicaps of cancer therapys is the difficulty of aiming these therapys at destroying cancerous cells without killing healthy cells in the process. But a newly released study by McMaster University scientists has provided insight into how researchers might develop therapies and drugs that more carefully target cancer, while sparing normal healthy cells........
Breast Cancer Gene Linked To Disease Spread
A team of scientists at Princeton University and The Cancer Institute of New Jersey has identified a long-sought gene that is fatefully switched on in 30 to 40 percent of all patients with breast cancer, spreading the disease, resisting traditional chemotherapies and eventually leading to death. The gene, called "Metadherin" or MTDH, is located in a small region of human chromosome 8 and may be crucial to cancer's spread or metastasis because it helps tumor cells stick tightly to blood vessels in distant organs. The gene also makes tumors more resistant to the powerful chemotherapeutic agents normally used to wipe out the deadly cells........
Hope for cancer straight from the heart
Digitalis-based drugs like digoxin have been used for centuries to treat patients with irregular heart rhythms and heart failure and are still in use today. In the Dec. 16 issue of the Proceedings of the National Academy of Sciences, scientists at the Johns Hopkins University School of Medicine now report that this same class of drugs may hold new promise as a therapy for cancer. This finding emerged through a search for existing drugs that might slow or stop cancer progression........
Family History of Prostate Cancer Has No Impact On The Treatment Outcomes
In a first of its kind study, a first-degree family history of prostate cancer has no impact on the therapy outcomes of patients with prostate cancer treated with brachytherapy (also called seed implants), and patients with this type of family history have clinical and pathologic characteristics similar to men with no family history at all, as per a January 1 study in the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology........
No cancer prevention potential for common vitamins
Women who took beta carotene or vitamin C or E or a combination of the supplements had a similar risk of cancer as women who did not take the supplements, as per data from a randomized controlled trial in the December 30 online issue of the Journal of the National Cancer Institute. Epidemiological studies have suggested that people whose diets are high in fruits and vegetables, and thus antioxidants, may have a lower risk of cancer. Results from randomized trials that address the issue, however, have been inconsistent and have rarely supported that observation........
Components of grape-seed may control leukemia
An extract from grape seeds forces laboratory leukemia cells to commit cell suicide, as per scientists from the University of Kentucky. They observed that within 24 hours, 76 percent of leukemia cells had died after being exposed to the extract. The investigators, who report their findings in the January 1, 2009, issue of Clinical Cancer Research, a journal of the American Association for Cancer Research, also teased apart the cell signaling pathway linked to use of grape seed extract that led to cell death, or apoptosis. They observed that the extract activates JNK, a protein that regulates the apoptotic pathway........
Taking one gene at a time in lung cancer
While examining patterns of DNA modification in lung cancer, a team of international scientists has discovered what they say is a surprising new mechanism. They say that "silencing" of a single gene in lung cancer led to a general impairment in genome-wide changes in cells, contributing to cancer development and progression........
Reason for failure of hormonal therapy of prostate cancer
The hormone deprivation treatment that patients with prostate cancer often take gives them only a temporary fix, with tumors commonly regaining their hold within a couple of years. Now, scientists at Johns Hopkins have discovered critical differences in the hormone receptors on prostate cancer cells in patients who no longer respond to this treatment. The findings, published in the Jan. 1 issue of Cancer Research, could lead to a way to track disease progression, as well as new targets to fight prostate cancer........
Nanoparticles aimed at cancer goes with a glitter
Using tiny gold particles and infrared light, MIT scientists have developed a drug-delivery system that allows multiple drugs to be released in a controlled fashion. Such a system could one day be used to provide more control when battling diseases usually treated with more than one drug, as per the researchers........
Are chemotherapy errors common?
Seven percent of adults and 19 percent of children taking chemotherapy drugs in outpatient clinics or at home were given the wrong dose or experienced other mistakes involving their medications, as per a newly released study led by Kathleen E. Walsh, MD, assistant professor of pediatrics at the University of Massachusetts Medical School, and reported in the January 1, 2009 issue of the Journal of Clinical Oncology.......
Food additive may increase speed spread of lung cancer
New research in an animal model suggests that a diet high in inorganic phosphates, which are found in a variety of processed foods including meats, cheeses, beverages, and bakery products, might speed growth of lung cancer tumors and may even contribute to the development of those tumors in individuals predisposed to the disease........
Cancer drug bortezomib find new uses
Scientists have discovered a new treatment for transplant patients, targeting the antibody-producing plasma cells that can cause organ rejection. Results of the study are reported in the Dec. 27, 2008, edition of the journal Transplantation Steve Woodle, MD, and his colleagues observed that a cancer drug bortezomib used to treat multiple myeloma, or cancer of the plasma cells, is effective in treating rejection episodes caused by antibodies that target transplanted kidneys and reversing rejection episodes that did not respond to standard therapies........
Important Note:
Do not delay in seeking advice from a qualified licensed medical professional about treatment for your cancer. The information presented here is no way meant to discourage you from undertaking conventional treatments for your cancer, but hopefully will support you and your doctor to undertake ’smarter’, more effective approaches to beat your cancer. The information is provided for educational and informational purposes only, and is not intended to be a substitute for the diagnosis, treatment and advice of a qualified licensed medical professional. The information is provided to support your informed consent to any treatment program you may decide to undertake. Self-treatment for clinical cancer is not advised. Statements regarding alternative treatments for cancer have not been evaluated by the FDA. Please consult your qualified licensed medical professional or appropriate health care provider about the applicability of any opinions or recommendations with respect to your own symptoms or medical conditions.
Powered by FirstRSS Plugin
